Tolperisone is a centrally-acting muscle relaxant with an excellent efficacy & safety profile.  It mediates muscle relaxation without concomitant sedation. Neither it causes impairment of coordination, weakness, mental confusion or withdrawal phenomena in contrast to other muscle relaxants. Primary indications for tolperisone will be acute muscle spasms in back pain and spasticity in neurological diseases. SANOCHEMIA has developed an instant release and several new sustained release formulations of tolperisone tablets.

In April 2007, SANOCHEMIA received regulatory approval to market tolperisone tablets in Germany for use in neurological disorders. SANOCHEMIA is now working to extend this registration to other European countries.
Go to top